Suppr超能文献

通过使用 Mitocans 作为新兴的抗癌药物靶向线粒体。

Targeting Mitochondria through the Use of Mitocans as Emerging Anticancer Agents.

机构信息

Faculty of Pharmacy, Victor Babes University of Medicine and Pharmacy, 2 Eftimie Murgu, Timisoara, Romania.

Earlscliffe Sixth Form, Earlscliffe, 29 Shorncliffe Road, Folkestone, CT20 2NB, United Kingdom.

出版信息

Curr Med Chem. 2020;27(34):5730-5757. doi: 10.2174/0929867326666190712150638.

Abstract

Mitochondria are key players with a multi-functional role in many vital cellular processes, such as energy metabolism, redox regulation, calcium homeostasis, Reactive Oxygen Species (ROS) as well as in cell signaling, survival and apoptosis. These functions are mainly regulated through important enzyme signaling cascades, which if altered may influence the outcome of cell viability and apoptosis. Therefore some of the key enzymes that are vital for these signaling pathways are emerging as important targets for new anticancer agent development. Mitocans are compounds aimed at targeting mitochondria in cancer cells by altering mitochondrial functions thus causing cell growth inhibition or apoptosis. This review summarizes the till present known classes of mitocans, their mechanism of action and potential therapeutic use in different forms of cancer.

摘要

线粒体在许多重要的细胞过程中起着关键作用,具有多功能性,例如能量代谢、氧化还原调节、钙稳态、活性氧(ROS)以及细胞信号转导、存活和细胞凋亡。这些功能主要通过重要的酶信号级联来调节,如果发生改变,可能会影响细胞活力和细胞凋亡的结果。因此,一些对这些信号通路至关重要的关键酶正成为开发新抗癌药物的重要靶点。Mitocans 是一类旨在通过改变线粒体功能来靶向癌细胞线粒体的化合物,从而导致细胞生长抑制或细胞凋亡。这篇综述总结了迄今为止已知的 Mitocans 类药物,它们的作用机制以及在不同形式的癌症中的潜在治疗用途。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验